To evaluate BDNF's capacity to modulate fibrin architecture under physiological conditions, rHu-BDNF was introduced into plasma aliquots from AIS/DM subjects (baseline BDNF: 7.0 ng/mL) prior to thrombin-triggered coagulation. This evidence concerns the gene BDNF and androgen insensitivity syndrome.